Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 27, 2014

View Archived Issues

Gut-targeted anti-TNF polyclonal antibody granted U.S orphan status for pediatric ulcerative colitis

Milestone Pharmaceuticals reports phase I data for MSP-2017

In vivo data show strong antitumor activity of the novel FGFR/VEGR inhibitor ODM-203

Endo acquires rights to Natesto testosterone nasal gel

OncoSec and UCSF collaborate to study pembrolizumab and ImmunoPulse in metastatic melanoma

Orgenesis receives grant for autologous hepatocyte-derived therapy for type 1 diabetes

Low-affinity NMDA channel blockers could be useful for Rett syndrome

Adiponectin-like peptide agonist useful for hepatic fibrosis

Amarantus reports preclinical data on MANF in a model of retinitis pigmentosa

Antiviral drug discovery companies Cocrystal Pharma and RFS Pharma complete merger

Phase I results demonstrate safety of CTO plus bevacizumab in patients with malignant glioma

Researchers present in vivo data for a novel highly selective aldosterone synthase inhibitor

Antibe Therapeutics discloses HS-releasing prostaglandin inhibitor for acute pain

Interferon gene signature suppression with sifalimumab and anifrolumab in patients with SLE

Nordic Nanovector and Affibody collaborate on radioimmunotherapies for multiple myeloma

FDA requests additional data on daclatasvir in combination with other HCV drugs

Vargatef approved in E.U. for second-line treatment of NSCLC

Brd4 inhibitors prepared and tested at Gilead Sciences

Janssen patent describes compounds for HBV infection

Boehringer Ingelheim reports development of ACC2 inhibitors

Merck & Co. divulges HIV integrase inhibitors

FDA issues complete response letter for Avanir's AVP-825 for migraine

Spanish researchers describe HDAC inhibitors

Intra-Cellular Therapies initiates phase III trial of ITI-007 in schizophrenia

Regen BioPharma acquires cancer stem cell intellectual property from University of Toronto

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...